• A
  • A
  • A

Clinical Trials

The Department of Surgery is committed to excellence in research, in order to find new and better treatments for our patients, as part of our commitment to excellence in patient care.

We currently are performing a variety of clinical trials to evaluate the effectiveness of potentially new treatment options related to the surgical specialties represented by our physicians.

Our goal is to give patients the opportunity to participate in approved and exploratory therapies without long-distance travel.

Participation in our clinical trials is always completely voluntary and
never interferes with the normal standards for patient care.

Our clinical trials enable us to use, in addition to established therapies, the newest and most advanced technologies and treatments — long before they are available to other physicians.

Patients participate in our clinical trials only after they receive a complete explanation of their options from their surgeon and surgical team.

Selected Clinical Trials Now Being Conducted by Our Faculty
  • Abdominal aortic aneurysm. Studying a new endovascular aortic securement system to improve AAA repair grafts (more).
  • Abdominal aortic aneurysm. Studying a new endovascular stent graft to repair AAAs below the kidneys (more).
  • Abdominal aortic aneurysm. Studying women who are underrepresented candidates for AAA repair (more).
  • Abdominal aortic, aorto-iliac, and iliac aneurysms. Studying the safety and effectiveness of a stent graft used along with an iliac leg graft to surgically treat abdominal aortic, aorto-iliac, and iliac aneurysms (more).
  • Aortic stenosis. Studying a blood-thinning anticoagulation/antiplatelet regimen in patients undergoing transcatheter aortic valve replacement (TAVR) for severe, symptomatic aortic stenosis who are low‐risk for surgical valve replacement (more).
  • Aortic stenosis. Studying the safety and feasibility of transcatheter aortic valve replacement (TAVR) in elderly patients with severe, symptomatic aortic stenosis who are low‐risk for surgical valve replacement (more).
  • Carotid artery disease. Studying the real-world usage of the stent for transcarotid artery revascularization when used by physicians of varying levels of training and previous experience with the transcarotid technique (more).
  • Colorectal or ileorectal anastomosis. Studying best practices for the use of sealant in patients undergoing colorectal and ileorectal stapled anastomotic procedures (more).
  • Gallbladder surgery. Studying use of new imaging devices for identifying anatomy during laparoscopic surgery for gallbladder removal.
  • Leg ischemia. Studying the effectiveness of the best available surgical treatment versus the best available endovascular treatment in adults with critical limb ischemia (more).
  • Lung cancer. Studying the safety and efficacy of cryoablation therapy used to treat tumors in patients with pulmonary metastatic disease (more).
  • Paraesophageal hernia. Studying the use of synthetic versus biologic mesh in hiatal hernia repair, two currently accepted standard of care surgical modalities (more).
  • Peripheral artery disease. Studying the safety and effectiveness of rivaroxaban combined with aspirin in reducing the risk of major cardiovascular events (such as stroke or heart attack) after a revascularization procedure to improve blood flow in the leg (more).
  • Postoperative nausea and emesis. Studying the effect of a postoperative nausea and vomiting-specific intervention following the bariatric procedure laparoscopic sleeve gastrectomy (more); contact 631-638-0292.
  • Post-thrombotic syndrome. Studying the use of image-guided, endovascular therapy to reduce disease severity and to improve quality of life in patients with established disabling post-thrombotic syndrome (more); contact 800-345-VEIN (8346).
  • Pulmonary embolism. Studying a temporary or permanent placed vein filter for patients who need to prevent blood clots forming in the lungs because they can't take anticlotting "blood thinner" medicines (more).
  • Thoracic aortic aneurysm. Studying the long-term performance of the Relay® Thoracic Stent-Graft used in patients with thoracic aortic aneurysms and penetrating atherosclerotic ulcers (more).
  • Venous leg ulcer. Studying the safety and efficacy of weekly applications of treatment venous leg ulcers present for at least four weeks (more).
  • Ventral hernia. This study aims to assess the effect of different levels of muscle relaxation on the success of low-pressure insufflation, surgical conditions, and patient recovery following laparoscopic repair of a ventral hernia between 2 and 10 cm in diameter (more); contact 631-638-0292.

For more information about our current clinical trials, please email our department research coordinator Andreea Fodor, PhD, or call her at 631-444-8333.

For more information about our current cancer-related clinical trials, please email the director of cancer clinical trials Ryan Washington, or call him at 631-216-2970.